Scinai Immunotherapeutics Ltd

SCNI

Company Profile

  • Business description

    Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai’s drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

  • Contact

    Hadassah Ein Kerem Campus
    2nd Floor, Jerusalem BioPark
    Jerusalem
    ISR

    T: +972 89302529

    https://www.scinai.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    31

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,804.1024.60-0.28%
CAC 407,766.7143.240.56%
DAX 4024,206.91133.240.55%
Dow JONES (US)44,240.76165.60-0.37%
FTSE 1008,854.1847.650.54%
HKSE23,970.76177.31-0.73%
NASDAQ20,418.465.950.03%
Nikkei 22539,677.4211.39-0.03%
NZX 50 Index12,775.7483.28-0.65%
S&P 5006,225.524.46-0.07%
S&P/ASX 2008,566.1024.60-0.29%
SSE Composite Index3,509.5712.100.35%

Market Movers